cystatin B
| GO Term | Evidence Code | PMID |
|---|---|---|
| adult locomotory behavior | ||
| negative regulation of peptidase activity | ||
| negative regulation of proteolysis |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region | ||
| extracellular space | ||
| extracellular space | ||
| nucleus | ||
| nucleolus |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protease binding | ||
| protease binding | ||
| RNA binding | ||
| endopeptidase inhibitor activity | ||
| cysteine-type endopeptidase inhibitor activity |
| Gene Ontology |
|---|
| endopeptidase inhibitor activity |
| InterPro |
|---|
| Cystatin domain |
| Cystatin superfamily |
| Proteinase inhibitor I25, cystatin, conserved site |
| Proteinase inhibitor I25A, stefin |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0111452 | progressive myoclonus epilepsy 1A | |
| DOID:3535 | Unverricht-Lundborg syndrome |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025